Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Stopped early · Not applicable

Conditions studied: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

In brief

The purpose of this research study is to determine whether and when patients with human papilloma virus positive squamous cell cancer of the oropharynx treated with radiation and chemotherapy clear their human papilloma virus infection.

Key facts

Study ID

NCT02045186

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

1

Starts

2013-12-01

Expected to finish

2014-11-01

Last updated by the study team

2017-05-04

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 18 years of age (no upper age limit)
• AnyT, AnyN, M0 squamous cell carcinoma of the oropharynx
• Biopsy proven squamous cell carcinoma that is HPV positive via standard pathological assessment of tumor tissues in pathology department at the treating institution
• Scheduled for definitive CRT as primary treatment of their oropharynx cancer

You may not qualify if…

• Prior history of radiation therapy to the head and neck
• Prior history of mucosal head and neck cancer.
• Not willing or able to comply with study specific procedures

Where it is running

• University of North Carolina at Chapel Hill, Department of Radiation Oncology — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.